← Back to Screener
Nutriband Inc. Warrant (NTRBW)
Price$1.20
Favorite Metrics
Price vs S&P 500 (26W)-45.85%
Price vs S&P 500 (4W)-17.57%
All Metrics
Price vs S&P 500 (YTD)-28.77%
10-Day Avg Trading Volume0.00M
3-Month Avg Trading Volume0.00M
52-Week Price Return-1.71%
52-Week High$4.50
26-Week Price Return-37.11%
13-Week Price Return-29.71%
3-Month Return Std Dev77.71%
Price vs S&P 500 (52W)-38.66%
Year-to-Date Return-25.78%
5-Day Price Return3.91%
Month-to-Date Return6.70%
Price vs S&P 500 (13W)-32.57%
Beta2.85x
52-Week Low$0.80
Industry Peers — Orthopedic & Prosthetic Devices(26)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
NTRBWNutriband Inc. Warrant | — | — | — | — | $1.20 |
ISRGIntuitive Surgical Inc. | 16.54x | 18.22% | 66.00% | 29.27% | $465.60 |
EWEdwards Lifesciences Corp | 7.77x | 6.70% | 78.01% | 18.41% | $81.44 |
STESTERIS plc | 3.81x | 12.49% | 44.11% | 17.03% | $226.41 |
ZBHZimmer Biomet Holdings, Inc. | 2.31x | 3.22% | 69.71% | 13.34% | $95.48 |
ALGNAlign Technology Inc | 3.41x | 10.30% | 68.27% | 13.53% | $191.66 |
SNNSmith & Nephew plc | 2.37x | 6.21% | 68.01% | 12.88% | $34.21 |
MSAMine Safety Incorporated | 3.60x | 6.82% | 46.46% | 19.83% | $173.50 |
ESTAEstablishment Labs Holdings Inc. | 9.30x | 20.04% | 69.32% | -18.48% | $66.93 |
ENOVEnovis Corporation | 0.68x | -6.05% | 58.16% | -50.09% | $26.27 |
CDRECadre Holdings, Inc. | 2.19x | 8.57% | 42.54% | 11.04% | $30.51 |
About
Nutriband Inc develops transdermal pharmaceutical products designed to prevent opioid abuse, diversion, and misuse. The company's proprietary AVERSA technology incorporates aversive agents into transdermal formulations to discourage drug abuse. Revenue is primarily generated through the sale of consumer transdermal and coated pharmaceutical products.